Awards are available for successful applicants from LMICs to cover the cost of their travel, accommodation and single-entry visa.
Meeting summary:
Artificial intelligence (AI) is increasingly being used in global health research but frameworks, policy and best practice for the ethical review and oversight of AI-enabled studies is currently lacking. The Forum will discuss how traditional research ethics regulatory frameworks have responded to the rapid advances in AI technology, and what changes are required, including to the role and responsibility of research ethics committees (RECs). It will explore the ethical challenges such as bias, privacy, data provenance and ownership, along with the need for transparency, accountability and engagement during the design and use of AI in global health research. To date, these discussions have predominantly taken place in high-income countries, and low- and middle-income country (LMIC) perspectives have been underrepresented. The Forum will consider the LMIC context where AI has the potential to address critical skills shortages and improve access to care, but where the ethical challenges are made harder due to existing disparities in infrastructure, knowledge and capacity. The Forum will take a multidisciplinary approach to explore how AI technology is being designed and used in health research, reflecting the range of actors involved in this space and the importance of computer scientists and technologists who apply AI for health to understand research ethics frameworks and considerations.
As part of the upcoming meeting, the GFBR is seeking case studies that bring attention to key ethical issues that have emerged regarding the use of AI in health research in LMIC settings and proposals to participate in a session on governance issues. The GFBR is also seeking participants to attend the meeting, with places awarded on a competitive basis.
Full details on how to apply are available on the GFBR website and the background paper provides further details on the meeting theme.
The deadline for applications is 17.00 CET on 17 June 2022.
In his EDCTP-GSK Senior Fellowship, Professor George Boateng Kyei of the Noguchi Memorial Institute for Medical Research, University of Ghana, has not only advanced the search for an HIV cure but also strengthened research capacity across Ghana and the broader African region.
HIV remains a pressing public health issue in Africa, with persistent challenges hindering the quest for a cure. This fellowship project focused on one such challenge: the virus’s ability to remain dormant within resting CD4+ T cells, even among individuals receiving antiretroviral therapy (ART). By exploring the innovative “shock and kill” approach, the research aimed to reactivate latent HIV and target infected cells for destruction. A notable scientific achievement was the identification and confirmation of three novel epigenetic compounds capable of reactivating latent HIV from virologically suppressed individuals. These findings pave the way for future studies in animal models, with the potential to transition into clinical trials aiming at finding a cure for HIV.
The establishment of a drug screening platform at the University of Ghana stands out as a long-term asset for HIV drug discovery and cure research. Additionally, the project introduced regular viral load monitoring for a substantial cohort of patients—an essential practice previously not standard in Ghana. The data generated from this monitoring has been instrumental in shaping national HIV treatment policies and improving patient care.
Furthermore, the project developed a biobank and a well-characterised cohort of HIV-infected adults, providing invaluable resources for ongoing and future HIV cure research. Insights gathered from patients regarding their perceptions of HIV cure research will inform the design and conduct of subsequent studies in Ghana and across Africa.
The impact of the fellowship extends beyond laboratory accomplishments; it has significantly influenced research training and career development. The fellowship helped nurture the growth of junior scientists, many of whom have evolved into independent research leaders, securing competitive grants and fellowships, such as the IAS Research-for-Cure Academy and NIH R21. They have presented their findings at prestigious international conferences, including the African Virology Congress and the American Society of Tropical Medicine and Hygiene (ASTMH).
Post-doctoral fellows have notably received fellowships from esteemed international programmes, such as the Science by Women Fellowship and the NIH CFAR Africure award, showcasing their growing prominence in the research community.
Professor Kyei’s mentorship has not gone unnoticed; in April 2024, he received special recognition from the University of Ghana’s Centre for Gender Studies and Advocacy (CEGENSA) for his outstanding mentorship of female academics—an honour highlighted by nominations from his own mentees. The project also celebrated the achievements of its team members, with one post-doc winning Best Senior Research Fellow at the 2024 NMIMR Awards and research assistants earning accolades at the 2024 African Virologist Conference.
Professor Kyei’s research has led to significant international visibility, with his team members winning travel awards to attend prestigious conferences, including the Keystone Symposium and the African Virology Congress. These opportunities have allowed them to present their findings and collaborate with global experts in the field.
The EDCTP-GSK Senior Fellowship grant has facilitated the groundwork for additional projects, including a newly awarded Fogarty grant aimed at enhancing HIV basic science and cure research training at the University of Ghana. This grant will train 17 researchers over the next 5 years, further strengthening the research landscape in Ghana.
As the team looks to the future, plans are in place to expand research into HIV reservoir characteristics among virologically suppressed patients across Ghana. This extension not only continues the momentum generated by the EDCTP grant, but also reinforces Ghana’s position as a leader in HIV cure research in Africa and contributes to the global effort to eradicate HIV.
Dear Colleague,
Are you attending the EDCTP 2025 forum in Kigali (Rwanda)?
Don't miss the Communications workshop on Thursday 19 June (15:30 - 17:30 Rwanda time) in room MH3.
The topic of the workshop will be: "From good to great: Mastering communication skills for impactful science
Best,
The EDCTP team.
Dear Stakeholder
Science Forum South Africa 2025 (SFSA 2025) will take place from 24 to 28 November 2025 at the CSIR International Convention Centre (CSIR ICC) in Pretoria, South Africa. This year marks the tenth edition of SFSA, celebrating a decade of igniting vibrant discussions on the role of science in society. The Forum brings together stakeholders from the scientific community, government, industry, and civil society.
We are pleased to invite proposals from individuals and institutions to convene panel sessions as part of the SFSA 2025 programme. These sessions should align with the Forum's theme and sub-themes, and provide an opportunity to engage diverse perspectives in critical conversations.
Igniting Conversations: Placing Science, Technology, and Innovation at the Centre of Government, Education, Society, and Industry
The deadline for proposal submissions is 21 July 2025.
SFSA 2025 is proudly co-hosted by the South African Department of Science, Technology and Innovation (DSTI) and the Science Diplomacy Capital for Africa (SDCfA) initiative.
We look forward to your participation in shaping the dialogue at SFSA 2025.
Best regards
The SFSA 2025 Organising Committee